Skip to main content
ProPhase Labs, Inc. logo

ProPhase Labs, Inc. — Investor Relations & Filings

Ticker · PRPH ISIN · US74345W1080 US Manufacturing
Open in API
Filings indexed 647 across all filing types
Latest filing 2026-06-01 Annual Report
Country US United States of America
Listing US PRPH

About ProPhase Labs, Inc.

https://www.prophaselabs.com/

ProPhase Labs, Inc. is a diversified biotechnology, genomics, and diagnostics company focused on developing, manufacturing, and commercializing health and wellness solutions. The company operates CLIA-certified laboratories to provide diagnostic and genomics testing services for healthcare providers and consumers. In addition to its diagnostics and genomics operations, ProPhase Labs offers contract manufacturing services and develops dietary supplements and other consumer health products.

Recent filings

Filing Released Lang Actions
10-K
Annual Report
2026-06-01 English
NT 10-K
Regulatory Filings
2026-03-27 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to disclose material events or changes that are important to shareholders. The text mentions the initiation of a potential sale or strategic partnership process and provides updates on legacy COVID-19 testing receivables. It includes a press release as an exhibit but does not contain comprehensive financial statements or detailed financial analysis. The document length is 4489 characters, which is relatively short and consistent with a current report rather than a full financial report. There is no indication that this is an Annual Report, Quarterly Report, or Earnings Release. The content focuses on a material event announcement rather than management discussion or audit information. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2026-02-13 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to disclose material events or changes that are important to shareholders. The text mentions a press release about an upcoming investor webinar and includes no financial statements or detailed financial data. The document is relatively short (3853 characters) and primarily serves as an announcement of an event and a press release. It does not contain an annual or quarterly report, audit information, or other detailed filings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2026-02-13 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to disclose material events or changes that are important to shareholders. The text mentions an operational update press release related to the company's activities, specifically about legacy COVID-19 testing receivables. The document is short (3807 characters) and primarily serves as a notification of an event rather than a detailed financial report or earnings release. It does not contain financial statements or detailed analysis but rather a press release as an exhibit. Therefore, it fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific types.
2026-01-27 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to disclose material events or changes that are important to shareholders. The text specifically mentions an event dated January 22, 2026, where ProPhase Labs, Inc. announced the uplisting of its common stock from the Pink Sheets to the OTCID Market. The document includes a press release as an exhibit and does not contain detailed financial statements or comprehensive financial data. The length of the document is 3724 characters, which is relatively short and consistent with a current report rather than a full financial report. This type of filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 8-K filings reporting material events.
2026-01-23 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.